Barnet planning chiefs quizzed on Hendon development times-series.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from times-series.co.uk Daily Mail and Mail on Sunday newspapers.
Drax is pleased to announce that it has signed an agreement (the Acquisition Agreement ) with Pinnacle Renewable Energy Inc. (PL.TO) ( Pinnacle ), providing for the acquisition by Drax Canadian Holdings Inc., an indirect, wholly-owned subsidiary of Drax, of the entire issued share capital of Pinnacle (the Acquisition ). The Acquisition will be implemented by way of a statutory plan of arrangement in accordance with the laws of the Province of British Columbia, Canada, at a price of C$11.30 per share (representing a premium of 13% based on the closing market price as at 5 February 2021 of C$10.04 per share and valuing the fully diluted equity of Pinnacle at C$385 million (£226 million
Dublin, London | 27 January 2021: Uniphar plc (the Company or Uniphar ) is pleased to announce the appointment of James ( Jim ) Gaul and Elizabeth ( Liz ) Hoctor to its Board as independent non-executive Directors with immediate effect. Jim Gaul Jim Gaul is an experienced executive and non-executive director with a strong track record in financial management in multinational pharmaceutical and healthcare sector companies. He is a former CFO of Sanofi Ireland, with thirty years experience in companies across the healthcare value chain, from early stage/R&D pharma to patient-facing hospital services. Jim is also former CFO of Mount Carmel Private Hospital. Jim is a Certified Public Accountant with experience in financial management, successful strategic business modelling and achieving business growth. He has an interest and experience in the achievement of success through people and is an experienced change manager and mentor with a focus on
Headquartered in Dublin, Ireland, Uniphar plc ( Uniphar and together with its subsidiaries the Group ) is an international diversified healthcare services business, servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions - Commercial & Clinical, Product Access and Supply Chain & Retail.
The Group has strong established relationships with 7 of the top 10 pharma companies and 6 of the top 10 medical device companies. With a workforce of more than 2,500, the Group is active in Ireland, the UK, the Benelux, the Nordics and the US, delivering unlicensed and specialty medicine on a global basis.
The Group s vision is to improve patient access to pharmaco-medical products and treatments by enhancing connectivity between manufacturers and healthcare stakeholders. Uniphar represents a strong combination of scale, growth and profitability.
Uniphar PLC (Ireland:UPR) | RNS | Uniphar PLC - Currency Change on LSE proactiveinvestors.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.co.uk Daily Mail and Mail on Sunday newspapers.